Skip to main content

Advertisement

Log in

Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”

  • Letter to the editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brans B, Bodei L, Giammarile F, Linden O, Luster M, Oyen WJG, et al. Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”. Eur J Nucl Med Mol Imag 2007;34:772–86.

    Article  CAS  Google Scholar 

  2. Seidlin SM, Marinelli MD, Oshry E. Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of thyroid. J Am Med Assoc 1946;132:838–47.

    Google Scholar 

  3. Wiseman GA, White CA, Sparks RB, Erwin WD, Podoloff DA, Lamonica D, et al. Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin’s lymphoma. Crit Rev Oncol Hematol 2001;39(1–2):181–94.

    Article  PubMed  CAS  Google Scholar 

  4. Matthay KK, Panina C, Huberty J, Price D, Glidden DV, Tang HR, et al. Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma. treated with I-131-MIBG. J Nucl Med 2001;42(11):1713–21.

    PubMed  CAS  Google Scholar 

  5. Sgouros G, Kolbert KS, Sheikh A, Pentlow KS, Mun EF, Barth A, et al. Patient-specific dosimetry for I-131 thyroid cancer therapy using I-124 PET and 3-dimensional-internal dosimetry (3D-ID) software. J Nucl Med 2004;45(8):1366–72.

    PubMed  CAS  Google Scholar 

  6. Hänscheid H, Lassmann M, Luster M, Thomas SR, Pacini F, Ceccarelli C, et al. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal. J Nucl Med 2006;47(4):648–54.

    PubMed  Google Scholar 

  7. ICRU report 67. Dose specifications in nuclear medicine. ICRU 2002.

  8. Health protection of individuals against the dangers of ionising radiation in relation to medical exposure: Council directive 97/43 EURATOM 1997.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Glenn Flux.

Additional information

The authors are members of the EANM Dosimetry Committee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Flux, G., Bardies, M., Chiesa, C. et al. Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”. Eur J Nucl Med Mol Imaging 34, 1699–1700 (2007). https://doi.org/10.1007/s00259-007-0471-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-007-0471-9

Keywords

Navigation